Starpharma Holdings Limited

Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced the first commercial product launch based on its Priostar(R) dendrimer technology. The product, a research reagent kit called NanoJuiceTM Transfection Kit for transporting DNA into cells, was developed under a license and supply agreement established in February 2007 between Starpharma's wholly owned US subsidiary Dendritic Nanotechnologies (DNT) and EMD Chemicals Inc., an affiliate of Merck KGaA, Darmstadt, Germany.

Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) advises that CEO Dr Jackie Fairley is today presenting at the Excellence in Biotechnology Investment 2008 conference in Sydney.

Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced that recent studies have shown that SPL7013, the active ingredient in its topical microbicide VivaGel(R), inhibits clinically-relevant strains of the human papillomavirus (HPV) in laboratory tests.

Starpharma Holdings Ltd (ASX: SPL)(OTCQX: SPHRY) has filed a patent application for the use of SPL7013, the active ingredient in VivaGel(R), to inhibit hyaluronidase activity in the treatment or prevention of a number of diseases. The inhibitory activity was discovered during studies on the contraceptive activity of SPL7013, in which effects on hyaluronidase were examined due to the enzyme's involvement in the fertilization process.

Starpharma Holdings Ltd (ASX:SPL)(OTCQX: SPHRY) today announced the signing of an agreement with Unilever, to co-develop a research tool using Starpharma's Priostar(R) dendrimer technology. An undisclosed fee is payable to Starpharma's US subsidiary DNT Inc as part of the arrangement.

Starpharma Holdings Limited (ASX: SPL) - 2007 AGM CEO's address - Dr Jackie Fairley, CEO; Starpharma Holdings Limited (ASX: SPL) present the following audio webcast regarding "2007 AGM CEO's address". You may also download this audio webcast to your computer or portable audio player.

Starpharma Holdings Limited (ASX: SPL) - Co-development Agreement with Durex for Condoms with VivaGel - Dr Jackie Fairley, CEO; Starpharma Holdings Limited (ASX: SPL) present the following audio webcast regarding "Co-development Agreement with Durex for Condoms with VivaGel". You may also download this audio webcast to your computer or portable audio player.

Starpharma Holdings Limited (ASX: SPL) - US NIH Funded Trial of VivaGel Commences - Dr Jackie Fairley, CEO; Starpharma Holdings Limited (ASX: SPL) present the following audio webcast regarding "US NIH Funded Trial of VivaGel Commences".

Starpharma Holdings Limited (ASX: SPL) - Starpharma Joins Premier US OTC Index - Dr Jackie Fairley, CEO; Boardroomradio is pleased to announce that Starpharma Holdings Limited (ASX: SPL) has published an audio file.

Starpharma Holdings Limited (ASX: SPL) - 2006 AGM Chairman's Address - Mr Peter Bartels, Chairman; Boardroomradio is pleased to announce that Starpharma Holdings Limited (ASX: SPL) has published an audio file.